ETHZilla Corp — Director's Dealing 2022

May 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2022-05-19

Reporting Person: McGovern Jr. Donald A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-19	Common Stock	A	12409	$1.36	Acquired	50587	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-19	Non-Qualified Stock Option (right to buy)	$1.36	A	15000	Acquired	2032-05-19	Common Stock (15000)	Direct
2022-05-19	Non-Qualified Stock Option (right to buy)	$1.36	A	134121	Acquired	2032-05-19	Common Stock (134121)	Direct

Footnotes

F1: Issued in consideration for serving on the Board of Directors, as Lead Director, Chairman of the Audit Committee, and as a Member of the Compensation Committee and of the Risk, Safety and Regulatory Committee of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.

F2: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.

F3: The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.

F4: Granted in consideration for serving as Lead Director of the Company during 2021 and 2022 (to date). Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.